Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Iscience|July 23, 2024
Mesoporous manganese nanocarrier target delivery metformin for the co-activation STING pathway to overcome immunotherapy resistanceYuanyao Dou, Jie Zheng, Jun Kang, et al.Frontiers in Molecular Biosciences|March 14, 2022
Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING UbiquitinationZhiguo Wang, Conghua Lu, Kejun Zhang, et al.Communications Biology|February 24, 2022
Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signalingLi Li, Zhujun Li, Conghua Lu, et al.Japanese Journal of Clinical Oncology|September 18, 2023
Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistanceJie Zheng, Yuanyao Dou, Daijuan Huang, et al.Oncology Research|September 23, 2024
Metformin promotes anti-tumor immunity in STK11 mutant NSCLC through AXIN1-dependent upregulation of multiple nucleotide metabolitesZhiguo Wang, Kunlin Li, Conghua Lu, et al.Advanced Healthcare Materials|February 19, 2025
Multieffect Specific Nanovesicles for Homing Resistant Tumors and Overcoming Osimertinib-Acquired Resistance in NSCLCYuanyao Dou, Yihui Liu, Rui Han, et al.Thoracic Cancer|October 4, 2022
Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancerJie Zheng, Yubo Wang, Chen Hu, et al.Journal for Immunotherapy of Cancer|June 22, 2024
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effectConghua Lu, Ziyuan Gao, Di Wu, et al.Developmental Cell|August 14, 2025
Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasisJie Zheng, Han She, Rui Han, et al.Pageof 4